No Data
No Data
THERAPEUTIC SOLUTIONS INTL INC | 10-Q: Quarterly report
Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board
Therapeutic Solutions International Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company Therapeutic Solutions International, Inc. (TSOI)
Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy
Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using MRNA
Clinical Stage Cell Therapy Contributes to Personalized Immunotherapy Revolution Therapeutic Solutions International, Inc. (TSOI), announced today the publication of a peer-reviewed paper entitled "Advancing
Res Nova Biologics Announces First Cancer Patient Treated With FloraStilbene
Therapeutic Solutions International Immuno-Oncology Subsidiary Makes Abortion Pill-Based Drug Available by Prescription through Cure Stat Rx Compounding Pharmacy Therapeutic Solutions International, Inc. (TSOI),
Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils
Therapeutic Solutions International, Inc. (TSOI) announced today a patent filing covering the unanticipated finding that neutrophils, a type of white blood cell, when manufactured in a specific manner, are capable of
No Data